If you have been reading about body composition and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-01-22. Where a claim depends on a specific study, the study is described rather than over-claimed.
Documentation plays a practical role in maintaining consistent results across laboratories. Certificates of analysis list purity, identity, and testing methods, and batch numbers allow comparisons between lots. Records of storage temperature and handling history help investigators interpret unexpected findings. When a sample behaves anomalously, reviewing that documentation often reveals whether the cause lies in the material or in the assay conditions.
Laboratories identify and quantify retatrutide using reversed-phase high-performance liquid chromatography coupled to mass spectrometry. This approach separates the peptide from related impurities and confirms identity through mass-to-charge measurements. Purity is commonly reported as the area percentage of the main peak relative to the total chromatogram. Ultraviolet detection near 214 nanometers is also used for peptide quantification, while intact mass analysis checks the molecular weight against a reference value.
Retatrutide is an investigational peptide developed by a pharmaceutical company as a multi-receptor agonist for treating obesity and type 2 diabetes. The compound emerged from research into gut-hormone analogues that act on several receptors simultaneously rather than on a single target. Early preclinical work examined how combined activity at three distinct receptors might produce greater metabolic effects than single-receptor compounds. Published phase 2 results have described substantial reductions in body weight among participants, although the compound remains unapproved in most jurisdictions as of the mid-2020s.
Pharmacologically, retatrutide acts as a triple agonist at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor. Activation of the first two receptors is associated with improved insulin secretion and reduced appetite. The glucagon receptor component is thought to increase energy expenditure, a mechanism that distinguishes this molecule from dual-agonist compounds. Researchers continue to investigate how the three activities interact and whether the combined profile offers advantages that justify additional clinical testing.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized solid form |
| Solubility | Soluble in water | Dissolves readily in aqueous media |
| Typical storage | -20 degrees Celsius or colder | Frozen, protected from light |
| Primary assay | Reversed-phase LC-MS | Separates and identifies the peptide |
| Common synonyms | LY3437943; triple agonist | Research designations |
Identification and purity assessment typically rely on reversed-phase high-performance liquid chromatography, often paired with mass spectrometry. Mass measurement confirms the expected molecular mass and can reveal truncations or modifications. Peptide mapping and sequencing techniques provide sequence-level confirmation when needed. Because related peptide impurities can behave similarly in a single method, orthogonal techniques are usually combined. Reported purity values depend heavily on the method used and should be interpreted with that in mind.
Dissolution behavior depends on the amino acid sequence, the counterion content, and the buffer chosen. Many peptides disperse readily in water or mild aqueous buffers, while others require a small amount of organic co-solvent or a change in pH. Adsorption to plastic and glass surfaces can reduce the concentration of a solution over time, particularly at low concentrations. Filtration before analysis removes particulates, and aliquoting limits repeated freeze-thaw cycles that stress the material.
Research-grade peptide material is commonly supplied as a lyophilized powder, a form that limits degradation during transport and storage. Standard practice keeps such material cold and protected from light and moisture, with tighter conditions used for long-term archives. Once dissolved, solutions are generally considered less stable than the dry powder and are handled on shorter timescales. These established conventions derive largely from general peptide chemistry rather than from compound-specific evidence alone.
The three-receptor design places retatrutide in a distinct category relative to older incretin-based therapies. Single agonists target one receptor, and dual agonists target two. Adding a third target broadens the pharmacological footprint and introduces new trade-offs among efficacy, tolerability, and glucose control. How these trade-offs resolve in large trials is a central focus of current research.
Retatrutide is an investigational peptide studied for obesity and type 2 diabetes. It is a single synthetic molecule designed to activate three metabolic receptors simultaneously. The compound belongs to the incretin mimetic family, a group of peptides that imitate gut hormones involved in appetite and glucose control. Its research code is LY3437943, and it remains under clinical study rather than cleared for routine medical use.
Acting as a triple agonist, the molecule binds the GLP-1, GIP, and glucagon receptors. GLP-1 activity slows gastric emptying and dampens appetite, while GIP signaling contributes to insulin sensitivity and fat metabolism. Glucagon receptor engagement raises energy expenditure and encourages fat breakdown, although it can also elevate blood glucose. Combining three pathways is intended to yield larger weight reduction than single or dual agonists, and researchers continue to examine how the balance among them shapes tolerability.
Body composition is assessed with dual-energy X-ray absorptiometry or comparable methods, which separate fat mass from lean mass. Reported losses include both compartments, and the ratio between them is a subject of ongoing analysis rather than a settled result. Waist circumference, blood pressure, and lipid panels are collected as supporting measures. Resting energy expenditure and substrate oxidation are measured in smaller mechanistic studies, where glucagon receptor activity is expected to matter. These substudies are typically short and small, so their findings carry wide uncertainty.
Interpretation depends on study phase and duration. Phase 2 programs are powered for weight and safety signals, not for cardiovascular or renal outcomes, which require event-driven designs. Gastrointestinal events such as nausea, diarrhea, vomiting, and constipation are the most frequently reported adverse effects and tend to cluster around dose escalation. Small increases in heart rate have been described. Because follow-up after treatment discontinuation is limited, questions about weight regain and durability are open rather than answered.
Trial reports for this compound rely on a small set of repeated measures. Body weight is normally expressed as percent change from baseline at a fixed week, with absolute kilograms given secondarily. Glycemic endpoints include HbA1c, fasting glucose, and, in some protocols, continuous glucose monitoring summaries. Imaging endpoints such as MRI-derived proton density fat fraction quantify liver fat. Standardization matters because a percent change and a categorical responder analysis can tell different stories about the same dataset.
== Honours == In 1986, he was made an Officer of the Order of Canada in recognition for being "at the forefront of Canadian scientific research and an international leader in the field of neuroendocrinology". In 1994, he was made an Officer of the National Order of Quebec and promoted to the grade of Grand Officer on June 16, 2022. In 2004, he was made a Chevalier of the Légion d'honneur and was promoted to Officer in 2011. In 1981, he was made a Fellow of the Royal Society of Canada. In 1996, he was made a Fellow of the American Association for the Advancement of Science. He has received honorary degrees from University of Liège (1980), Paris Descartes University (1992), Laurentian University (1996), University of Guelph (1999), and Memorial University of Newfoundland (2000). In 2009, he was elected a Fellow of the Royal Society In 2017 he was made a member of the Canadian Medical Hall of Fame.
Naturally occurring cadmium is composed of eight isotopes. Two of them are radioactive, and three are expected to decay but have not measurably done so under laboratory conditions. The two natural radioactive isotopes are 113Cd (beta decay, half-life is 8.04×1015 y) and 116Cd (double beta decay, half-life is 2.69×1019 y). The other three are 106Cd, 108Cd (both double electron capture), and 114Cd (double beta decay); only lower limits on these half-lives have been determined. At least three isotopes – 110Cd, 111Cd, and 112Cd – are stable. Among the isotopes that do not occur naturally, the most long-lived are 109Cd with a half-life of 461.3 days, and 115Cd with a half-life of 53.46 hours. All of the remaining radioactive isotopes have half-lives of less than 7 hours, and the majority have half-lives of less than 5 minutes. Cadmium has 8 known meta states, with the most stable being 113mCd (t1⁄2 = 13.9 years), 115mCd (t1⁄2 = 44.6 days), and 117mCd (t1⁄2 = 3.44 hours).
==== Cholesterol synthesis ==== The cytosolic acetyl-CoA can also condense with acetoacetyl-CoA to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) which is the rate-limiting step controlling the synthesis of cholesterol. Cholesterol can be used as is, as a structural component of cellular membranes, or it can be used to synthesize steroid hormones, bile salts, and vitamin D.
Sources: en.wikipedia.org
== History == The spray drying technique was first described in 1860 with the first spray dryer instrument patented by Samuel Percy in 1872. With time, the spray drying method grew in popularity, at first mainly for milk production in the 1920s and during World War II, when there was a need to reduce the weight and volume of food and other materials. In the second half of the 20th century, commercialization of spray dryers increased, as did the number of spray drying applications.
== Blockers, absorbers, and windows == Ultraviolet absorbers are molecules used in organic materials (polymers, paints, etc.) to absorb UV radiation to reduce the UV degradation (photo-oxidation) of a material. The absorbers can themselves degrade over time, so monitoring of absorber levels in weathered materials is necessary. In sunscreen, ingredients that absorb UVA/UVB rays, such as avobenzone, oxybenzone and octyl methoxycinnamate, are organic chemical absorbers or "blockers". They are contrasted with inorganic absorbers/"blockers" of UV radiation such as titanium dioxide and zinc oxide. For clothing, the ultraviolet protection factor (UPF) represents the ratio of sunburn-causing UV without and with the protection of the fabric, similar to sun protection factor (SPF) ratings for sunscreen. Standard summer fabrics have UPFs around 6, which means that about 20% of UV will pass through. Suspended nanoparticles in stained-glass prevent UV rays from causing chemical reactions that change image colors. A set of stained-glass color-reference chips is planned to be used to calibrate the color cameras for the 2019 ESA Mars rover mission, since they will remain unfaded by the high level of UV present at the surface of Mars. Common soda–lime glass, such as window glass, is partially transparent to UVA, but is opaque to shorter wavelengths, passing about 90% of the light above 350 nm, but blocking over 90% of the light below 300 nm. A study found that car windows allow 3–4% of ambient UV to pass through, especially if the UV was greater than 380 nm.
Thiel and Angermayer agreed to invest after a lunch, also held for members of the gay tech community, around mid-2023. The Wired notes that Thiel and Angermayer were not particularly interested in sports, but D'Souza was a savvy fundraiser. Angermayer said his backing of TEG stems from his belief that AI will create more leisure time and boost demand for sports entertainment. He said, "Humans are wired to want to see the fastest man or woman [...] They don't want to see the fastest natural man."
=== Recycling === Nylons is typically used in durable goods, so it makes only a minor contribution to waste streams. Nylons are susceptible to hydrolysis, but the process is slow at room temperature and neutral pH, hence the utility of these materials. Being a robust polymer, nylon resin waste is not often recycled. The rate of hydrolysis increases in the presence of strong acids, a reaction essentially the reverse of their synthesis. Nylons are also the most popular fiber type in the residential carpet industry today. The US EPA estimates that 9.2% of carpet fiber, backing and padding was recycled in 2018, 17.8% was incinerated in waste-to-energy facilities, and 73% was discarded in landfills. Discarded nylon fishing gear such as fishing nets contributes to debris in the ocean. Its production however can use a closed loop during manufacturing, by grinding sprues and runners and mixing them with the virgin granules being consumed by the molding machine. The process of recycling post-consumer nylon waste is expensive and difficult, so few companies utilize it, favoring cheaper newly made plastics for their products instead. US clothing company Patagonia has sold products containing recycled nylon and in the mid-2010s invested in Bureo, a company that recycles nylon from used fishing nets to make sunglasses and skateboards. The Italian company Aquafil has also recycled nylon from fishing nets, to create apparel. Vanden Recycling recycles nylon and other polyamides (PA) and has operations in the UK, Australia, Hong Kong, the UAE, Turkey and Finland.
Sources: en.wikipedia.org
Dry powder is kept frozen, commonly at minus twenty degrees Celsius or below. It should be protected from light and moisture. Dissolved material is less stable and is generally used soon after preparation.
Mass spectrometry provides the intact molecular mass, and tandem mass spectrometry can confirm the sequence. Chromatographic retention time adds another layer of confirmation. These methods are usually applied together.
Impurities such as truncated or oxidized forms can alter experimental results. Purity data indicate how much of the sample is the intended molecule. Reputable analysis reports both purity and identity.
It is designed as a triple agonist acting on the GLP-1, GIP, and glucagon receptors. This combination is intended to influence appetite, insulin secretion, and energy expenditure. Single-receptor and dual-receptor compounds act on a narrower set of targets.